Previous close | 2.8400 |
Open | 2.8900 |
Bid | 2.8300 x 300 |
Ask | 2.8600 x 500 |
Day's range | 2.8400 - 3.0300 |
52-week range | 2.7000 - 6.2500 |
Volume | |
Avg. volume | 370,993 |
Market cap | 138.908M |
Beta (5Y monthly) | -0.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On April 11, 2024, Ian Shakil, Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 92,787 shares of the company.
On April 8, 2024, Ian Shakil, Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 89,167 shares of the company.
On April 4, 2024, Ian Shakil, the Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 109,961 shares of the company.